Delivery Order SPE2DB22D1017-SPE2DB25FG9EM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets in a 30-count unit configuration, valued at $8,022.27. This firm fixed price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by July 22, 2025. The contract reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems, with performance occurring at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $10,027.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. The contract, with an ultimate completion date of August 8, 2025, represents a pharmaceutical delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,539.97 to AmerisourceBergen Drug Corp for supply of Descovy 200-25 mg tablets (30-count units). This non-competitive, firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $20,176.14 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $16,346.38 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's proven...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $27,254.12, represents a non-competitive set-aside award with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This contract, valued at $19,707.30, represents a competitive award with firm fixed pricing and no set-aside designation. The delivery order is scheduled for completion by August 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order valued at $13,660.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9EMDelivery Order
The Defense Logistics Agency awarded a $37,229.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government, supporting military and veteran healthcare procurement needs. This delivery order is a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is positioned as a major pharmaceutical distributor and critical vendor for federal medical procurement, with demonstrated capability to fulfill competitive federal requirements across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 8/7/25 |